Qnexa
New Weight-Loss Drug Shows Promise in Trial
U.S. News & World Report | Fri, 11 May 2012 06:03:05 -0700
Volunteers who took Qnexa, a combination of the drugs phentermine and topiramate, experienced substantial weight loss, even if they had many weight-related health problems, the study found. The findings were reported this week during the European ...
U.S. News & World Report
Panel advises FDA to approve lorcaserin obesity pill
CBS News | Fri, 11 May 2012 10:31:24 -0700
FDA panel backs obesity pill Qnexa: What happens next? Secret to weight loss isn't through fad diets or pills, study shows Qnexa and the FDA: Why safe diet drugs are hard to come by The panel voted 18-4 with one abstention to recommend approval of ...
CBS News
VIVUS Reports First Quarter 2012 Financial Results
MarketWatch (press release) | Mon, 07 May 2012 13:02:08 -0700
The increase in net loss was primarily attributable to increased general and administrative expenses from spending on Qnexa pre-commercialization activities. VIVUS had cash, cash equivalents and available-for-sale securities (cash) of $333.4 million at ...
Qnexa: The Dangerous 'Silver Bullet' Weight Loss Pill
Diets In Review (blog) | Tue, 01 May 2012 08:05:27 -0700
And to clarify what exactly the silver bullet pill is, it's the controversial weight loss drug Qnexa, which has only received preliminary approval from an FDA advisory panel - not from the FDA. While Dr. Oz says may this be the 'magic bullet' America ...